Skip to main content
SpringerLink
Log in

Treatment Outcome Following Transarterial Chemoembolization in Advanced Bone and Soft Tissue Sarcomas

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

Transarterial chemoembolization (TACE) is used to treat unresectable bone and soft tissue sarcoma (STS) and as a pre-surgical adjuvant treatment. However, its efficiency for advanced STS is undetermined. This study evaluated TACE’s efficiency in treating advanced STS and prognostic factors for patient survival.

Materials and Methods

We enrolled 39 patients with unresectable STS who underwent TACE as an alternative treatment during 2010–2014, with overall survival (OS) as the primary end point. Cancer pain was evaluated by visual analogue scores (VAS) before and after TACE procedures. Factors that affect survival were evaluated by multivariate analyses (Cox proportional hazard model).

Results

Mean OS after TACE was 23.7 ± 2.1 months, with 1-year OS 71.5 %, 2-year OS 45.8 %, and 3-year OS 32.5 %. Lesion number and tumor stage were key predictors of survival. TACE was found to decrease cancer pain VAS and increase relapse interval. Size of polyvinyl alcohol (PVA) particle diameter (P = 0.03) and imaging response (P = 0.044) were also found to affect relapse interval.

Conclusion

TACE was an effective treatment for advanced STS, with a 32.5 % 3-year OS rate, and led to lower cancer pain VAS and longer relapse intervals than chemoinfusion only. Smaller PVA particles are preferable during the TACE procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    Article  PubMed  Google Scholar 

  2. Christie-Large M, James SL, Tiessen L, Davies AM, Grimer RJ. Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas. Eur J Cancer. 2008;44:1841–5.

    Article  CAS  PubMed  Google Scholar 

  3. Nakamura T, Grimer RJ, Carter SR, Tillman RM, Abudu A, Jeys L, Sudo A. Outcome of soft-tissue sarcoma patients who were alive and event-free more than five years after initial treatment. Bone Joint J. 2013;95-b:1139–43.

    Article  CAS  PubMed  Google Scholar 

  4. Kraybill WG, Harris J, Spiro IJ, Ettinger DS, DeLaney TF, Blum RH, Lucas DR, Harmon DC, Letson GD, Eisenberg B. Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: radiation Therapy Oncology Group Trial 9514. Cancer. 2010;116:4613–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Farfalli GL, Albergo JI, Ritacco LE, Ayerza MA, Muscolo DL, Aponte-Tinao LA. Oncologic and clinical outcomes in pelvic primary bone sarcomas treated with limb salvage surgery. Musculoskelet Surg. 2015;99:237–42.

    Article  CAS  PubMed  Google Scholar 

  6. Keung EZ, Hornick JL, Bertagnolli MM, Baldini EH, Raut CP. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. J Am Coll Surg. 2014;218:206–17.

    Article  PubMed  Google Scholar 

  7. Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, Nguyen Bui B, French Federation of Cancer Centers Sarcoma Group. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359–68.

    Article  CAS  PubMed  Google Scholar 

  8. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228(3):355–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bonvalot S, Miceli R, Berselli M, Causeret S, Colombo C, Mariani L, Bouzaiene H, Le Péchoux C, Casali PG, Le Cesne A, Fiore M, Gronchi A. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507–14.

    Article  PubMed  Google Scholar 

  10. Gronchi A, Miceli R, Colombo C, Stacchiotti S, Collini P, Mariani L, Sangalli C, Radaelli S, Sanfilippo R, Fiore M, Casali PG. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2012;23:1067–73.

    Article  CAS  Google Scholar 

  11. Nagata Y, Mitsumori M, Okajima K, Mizowaki T, Fujiwara K, Sasai K, Nishimura Y, Hiraoka M, Abe M, Shimizu K, Kotoura Y. Transcatheter arterial embolization for malignant osseous and soft tissue sarcomas. II. Clinical results. Cardiovasc Intervent Radiol. 1998;21:208–13.

    Article  CAS  PubMed  Google Scholar 

  12. Mavrogenis AF, Rossi G, Altimari G, Calabrò T, Angelini A, Palmerini E, Rimondi E, Ruggieri P. Palliative embolisation for advanced bone sarcomas. Radiol Med (Torino). 2013;118:1344–59.

    Article  CAS  Google Scholar 

  13. Zhang HJ, Yang JJ, Lu JP, Lai CJ, Sheng J, Li YX, Hao Q, Zhang SM, Gupta S. Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity. Cardiovasc Intervent Radiol. 2009;32:672–8.

    Article  PubMed  Google Scholar 

  14. Grimer Robert, Athanasou Nick, Gerrand Craig, Judson Ian, Lewis Ian, Morland Bruce, Peake David, Seddon Beatrice, Whelan Jeremy. UK Guidelines for the management of bone sarcomas. Sarcoma. 2010;2010:317462.

    PubMed  PubMed Central  Google Scholar 

  15. Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma. 2010;2010:506182.

    PubMed  PubMed Central  Google Scholar 

  16. Angle JF, Siddiqi NH, Wallace MJ, Kundu S, Stokes L, Wojak JC, Cardella JF. Society of Interventional Radiology Standards of Practice, C. Quality improvement guidelines for percutaneous transcatheter embolization: society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol. 2010;21(10):1479–86.

    Article  PubMed  Google Scholar 

  17. Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY. Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2008;19(Suppl 2):ii89–93.

    Google Scholar 

  18. Cornelis F, Havez M, Lippa N, Al-Ammari S, Verdier D, Carteret T, Amoretti N, Gangi A, Palussiere J, Hauger O, Grenier N. Radiologically guided percutaneous cryotherapy for soft tissue tumours: a promising treatment. Diagn Intervent Imaging. 2013;94:364–70.

    Article  CAS  Google Scholar 

  19. Li C, Wu P, Zhang L, Fan W, Huang J, Zhang F. Osteosarcoma: limb salvaging treatment by ultrasonographically guided high-intensity focused ultrasound. Cancer Biol Ther. 2009;8:1102–8.

    Article  PubMed  Google Scholar 

  20. Callstrom MR, York JD, Gaba RC, Gemmete JJ, Gervais DA, Millward SF, Brown DB, Dupuy D, Goldberg SN, Kundu S, Rose SC, Thomas JJ, Cardella JF. Research reporting standards for image-guided ablation of bone and soft tissue tumors. J Vasc Intervent Radiol JVIR. 2009;20:1527–40.

    Article  Google Scholar 

  21. Chen W, Zhu H, Zhang L, Li K, Su H, Jin C, Zhou K, Bai J, Wu F, Wang Z. Primary bone malignancy: effective treatment with high-intensity focused ultrasound ablation. Radiology. 2010;255:967–78.

    Article  PubMed  Google Scholar 

  22. Foster RC, Stavas JM. Bone and soft tissue ablation. Semin Intervent Radiol. 2014;31(2):167–79.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Mavrogenis AF, Rossi G, Rimondi E, Calabro T, Papagelopoulos PJ, Ruggieri P. Palliative embolization for osteosarcoma. Eur J Orthop Surg Traumatol Orthop Traumatol. 2014;24:1351–6.

    Article  Google Scholar 

  24. Young RJ, Natukunda A, Litiere S, Woll PJ, Wardelmann E, van der Graaf WT. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials. Eur J Cancer. 2014;50:3178–86.

    Article  CAS  PubMed  Google Scholar 

  25. Van Glabbeke M, van Oosterom AT, Oosterhuis JW, Mouridsen H, Crowther D, Somers R, Verweij J, Santoro A, Buesa J, Tursz T. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2185 patients treated with anthracycline-containing first-line regimens–a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol Off J Am Soc Clin Oncol. 1999;17:150–7.

    Google Scholar 

  26. Lee MY, Chuang VP, Wei CJ, Cheng TY, Cherng MT. Histopathologic correlation of hepatocellular carcinoma after transcatheter arterial chemoembolization with polyvinyl alcohol particle of various sizes. Eur J Radiol. 2012;81:1976–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was partly funded by Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai (No. PWZxq2014-07), funding of Science and Technology Commission of Shanghai Municipality (No. 12ZR1422700) and Shen-Kang Hospital Development Center Project of Shanghai (No. SHDC12014902), and this work was also supported by National Natural Science Fundation of China (No. 81271683).

Author information

Author notes

    Authors and Affiliations

    1. Department of Radiology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, 600 Yi-Shan Road, Shanghai, 200233, People’s Republic of China

      Chunyu Jiang, Jianbo Wang, Jungong Zhao, Yueqi Zhu, Xu Ma & Jia Zhou

    2. Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, 200233, People’s Republic of China

      Yonggang Wang

    3. Department of General Surgery, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Shanghai, 200233, People’s Republic of China

      Xuebing Yan

    Authors
    1. Chunyu Jiang
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Jianbo Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Yonggang Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Jungong Zhao
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Yueqi Zhu
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Xu Ma
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Jia Zhou
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Xuebing Yan
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Jianbo Wang.

    Ethics declarations

    Conflict of interest

    We declare that we have no financial and personal relationships with people or organizations that can inappropriately influence our work; there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled.

    Additional information

    Chunyu Jiang and Yonggang Wang have contributed equally to this work.

    Electronic supplementary material

    Below is the link to the electronic supplementary material.

    Supplementary material 1 (DOCX 24 kb)

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Jiang, C., Wang, J., Wang, Y. et al. Treatment Outcome Following Transarterial Chemoembolization in Advanced Bone and Soft Tissue Sarcomas. Cardiovasc Intervent Radiol 39, 1420–1428 (2016). https://doi.org/10.1007/s00270-016-1399-x

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00270-016-1399-x

    Keywords

    Search

    Navigation